CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Option exercise EVP, COO acquired 9,167 shares (option exercise)
- 4 Option exercise SVP, GC, BD & Corp Affairs acquired 7,334 shares (option exercise)
- 4 Option exercise President and CEO acquired 22,501 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Shareholder vote results
- 4 Option exercise SVP, CFO acquired 792 shares (option exercise)
- 4 Option exercise EVP, COO acquired 1,833 shares (option exercise)
- 4 Option exercise President and CEO acquired 4,792 shares (option exercise)
- DEFR14A Other DEFR14A
- DEFR14A Other DEFR14A
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 14 of 38 · 742 filings